2023
Exports
$182kWorld Rnk 125 / 208
Flag Rnk 224 / 765
2023
PRODUCT COMPLEXITY IN Vaccines, blood, antisera, toxins and cultures
1.25Rnk 89 / 1025
2023
Imports
$33.6MWorld Rnk 124 / 222
Flag Rnk 58 / 1155
2023
ECONOMIC COMPLEXITY of Zimbabwe
-0.98Rnk 110 / 132

About

Exports In 2023, Zimbabwe exported $182k in Vaccines, blood, antisera, toxins and cultures, making it the 125th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 224th most exported product in Zimbabwe. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Zimbabwe are: Switzerland ($97k), France ($53.7k), Botswana ($18.4k), India ($7.82k), and South Africa ($4.09k).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Zimbabwe between 2022 and 2023 were Switzerland ($97k), France ($37.2k), and Botswana ($15.2k).

Imports In 2023, Zimbabwe imported $33.6M in Vaccines, blood, antisera, toxins and cultures, becoming the 124th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 58th most imported product in Zimbabwe. Zimbabwe imports Vaccines, blood, antisera, toxins and cultures primarily from: South Africa ($6.83M), India ($5.9M), Belgium ($4.32M), Egypt ($3.68M), and China ($3.47M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Zimbabwe between 2022 and 2023 were Egypt ($3.68M), South Africa ($1.78M), and South Korea ($1.51M).

Latest Trends

Dec 2024

Subnational Monthly Trade

View
Flow
Y-AXIS SCALE

For a full breakdown of trade patterns, visit the trend explorer or the product in country profile.

The following visualization shows the latest trends on Vaccines, blood, antisera, toxins and cultures. Countries are shown based on data availability.

* Using January 2020 exchange rates when trade data is reported in local currency.

Explore Latest Trends

Subscribe today to OEC pro and access the latest data

Sign Up

Historical Data

Trade Balance

Color
EXPORTS (2023)$182k
IMPORTS (2023)$33.6M
NET TRADE (2023)-$33.4M

In 2023, Zimbabwe exported $182k in Vaccines, blood, antisera, toxins and cultures. The main destinations of Zimbabwe exports on Vaccines, blood, antisera, toxins and cultures were Switzerland ($97k), France ($53.7k), Botswana ($18.4k), India ($7.82k), and South Africa ($4.09k).

In 2023, Zimbabwe imported $33.6M in Vaccines, blood, antisera, toxins and cultures, mainly from South Africa ($6.83M), India ($5.9M), Belgium ($4.32M), Egypt ($3.68M), and China ($3.47M).

Explore Visualizations

Export Destinations (2023)

Import Origins (2023)

Market Growth

Flow
THE FASTEST GROWING Vaccines, blood, antisera, toxins and cultures EXPORT MARKETS FOR Zimbabwe WERE (2022 - 2023):
Switzerland$97k (462k%)
France$37.2k (226%)
Botswana$15.2k (470%)
THE FASTEST DECLINING MARKETS FOR THE EXPORT OF Vaccines, blood, antisera, toxins and cultures BY Zimbabwe WERE (2022 - 2023):
Namibia-$41k (-100%)
Zambia-$8.66k (-100%)
Spain-$7.61k (-100%)

Change in Exports by Market (2022 - 2023)

Market Concentration

View
Flow
Type
In 2023, Zimbabwe's main exporting competitors in Vaccines, blood, antisera, toxins and cultures were:
In 2023, Zimbabwe's main importing competitors in Vaccines, blood, antisera, toxins and cultures were:

Explore Visualizations

Trade Value of Vaccines, blood, antisera, toxins and cultures by Exporters

Potential Exports

Potential Exports

Flow
View
TOP EXPORT POTENTIALFrance+ $54.8k
TOP IMPORT POTENTIALBelgium+ $4.54M

Vaccines, blood, antisera, toxins and cultures’s highest export potential is France. With an export gap of $54.8k.   Vaccines, blood, antisera, toxins and cultures’s highest import potential is Belgium with an import gap of $4.54M.

See methodology.

Subscribe today to OEC pro and access the latest data

Sign Up

Have questions, comments, or concerns?
Send us an e-mail: support@oec.world
Follow @OECtoday on
Created, Designed, and Developed by:
In collaboration with